Web3 ago 2024 · Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002) Authors (first, second … WebBackground: Gastric cancer with extensive lymph node metastasis is commonly regarded as unresectable, while preoperative chemotherapy followed by gastrectomy has been tested …
(PDF) A phase II study of preoperative chemotherapy with …
WebJCOG0405 or JCOG1002. Following the protocol of JCOG 0405 and JCOG1002, gastrectomy with D2 plus para-aortic nodal dissection was performed. Other trials needed D2 lymphadenec-tomy. The histological tumor regression of primary tumor was evaluated with the Japanese Classification of Gastric Carcinoma (JCGC) [17]. The definitions of … Web14 giu 2016 · JCOG1002, which aimed to explore the efficacy of triplet chemotherapy with the addition of docetaxel to CS, was introduced after JCOG0405 [18]. gary smith hockey goalie
Advances in para-aortic nodal dissection in gastric cancer surgery: …
Web1 feb 2024 · Request PDF Long-term outcome of preoperative docetaxel with cisplatin plus S-1 therapy for advanced gastric cancer with extensive nodal metastasis (JCOG1002). 141 Background: Neoadjuvant ... Web18 gen 2024 · JCOG1002, which aimed to explore the efficacy of triplet chemotherapy with the addition of docetaxel to CS, was introduced after JCOG0405 . However, no … Web14 ott 2024 · The JCOG1002 investigated the efficacy of a triplet regimen with docetaxel, cisplation, and S-1, but the primary endpoint of the clinical response rate of 57.7% was less than the threshold value of 65% . Moreover, the 5-year overall survival rate (54.9%) was similar to and did not exceed that of the JCOG0405. gary smith honda ft walton beach